Form S-1/A Monopar Therapeutics
Tweet
Share
E-mail
http://archive.fast-edgar.com/20190910/AVA2O22CZC22DJZ2222D2ZZCQH9GRS2282B2
Filed on: September 10, 2019
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Raises S&P500 Target to 8,100
- Laser Photonics prices $7.9M public offering at $0.75 per share
- FDA grants Bayer's HYRNUO accelerated approval as first-line NSCLC therapy
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
S1Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
